Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Some men with early hair loss may have a condition similar to PCOS in women.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Valproic acid and carbamazepine do not change biotin or biotinidase levels but may lower zinc levels, still within normal range.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

Obesity and negative body image harm mental health and quality of life in women with PCOS.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

PCOS causes hormonal imbalances, irregular periods, and can lead to infertility, obesity, and mental health issues.